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W ar b ur g ( 1 ), h as g o n e a l o n g  w a y fr o m a n i ntri g ui n g s ci e ntifi c
o bs er v ati o n t o a v ali d at e d dr u g t ar g e t i n t h e cli ni c. I niti all y b eli e v e d
t o s er v e as a n alt er n ati v e e n er g y s o ur c e f or t h e r a pi dl y di vi di n g
c a n c er c ells, “W ar b ur g ’s eff e ct” of o xi d ati v e gl y c ol ysis is n o w
c o nsi d er e d a n eff e cti v e  m e a ns of  m et a b oli c r e wiri n g  w hi c h
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a p pr o a c h es ar e ur g e ntl y r e q uir e d es p e ci all y f or hi g h ris k gr o u ps,
r efr a ct or y dis e as e, a n d r el a ps e d p ati e nts.
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alr e a d y a p pr o v e d f or t h e tr e at m e nt of a c ert ai n c o n diti o n, is
tr a nsf err e d i nt o a diff er e nt dis e as e c o nt e xt.  T h e a d v a nt a g e of t his
a p pr o a c h is s a vi n g c o nsi d er a bl e a m o u nt of ti m e ( at l e ast 2 – 3
ti m es q ui c k er (1 8 )) a n d  m o n e y ( 3– 1 0 ti m es l ess o n a v er a g e ( 1 9 )),
ulti m at el y tr a nsl ati n g i nt o s a vi n g  m or e li v es f ast er a n d at a l o w er
c ost. E n c o ur a gi n g e x a m pl es of dr u g r e p ositi o ni n g alr e a d y i n us e
or i n cli ni c al tri als r a n g e fr o m  As piri n i n c ol or e ct al c a n c er ( 2 0 ),
M etf or mi n (f or di a b et es) a n d  D a u n or u bi ci n ( a nti bi oti c) f or
v ari o us  m ali g n a n ci es ( 2 0 , 2 1 ), r eti n oi c a ci d ( vit a mi n  A) i n
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At o v a q u o n e ( At o) is a n a n al o g u e of u bi q ui n o n e (t h e o xi dis e d
f or m of c o e n z y m e  Q 1 0)  m a ki n g it a n eff e cti v e i n hi bit or of c o m pl e x
III of t h e el e ctr o n tr a ns p ort c h ai n ( E T C) (2 4 ).  D u e t o its hi g h
s p e cifi cit y a n d e x c ell e nt t ol er a bilit y  At o h as b e e n us e d a g ai nst
pr ot o z o a li k e Pl as m o di u m s p p a n d T o x o pl as m a g o n dii , t ur ni n g it
i nt o a k e y c o m p o n e nt of st a n d ar d a nti- m al ari al t h er a p y i n cl u di n g i n
c hil dr e n ( 2 5 ). I nt er esti n gl y, i n r e c e nt y e ars  At o h as b e e n hi g hli g ht e d
as a p ot e nt a nti- pr olif er ati v e a n d a p o pt oti c a g e nt i n diff er e nt
m ali g n a n ci es. F or i nst a n c e ,  At o h as pr o v e d eff e cti v e i n vitr o i n
br e ast c a n c er ( 2 6 ), i n p h ar y n g e al a n d c ol or e ct al c a n c er c ell li n es i n
e n h a n ci n g t h e eff e ct of r a di ot h er a p y ( 2 7 ), i n r eti n o bl ast o m a c ells
(2 8 ), a n d i n h a e m at ol o gi c  m ali g n a n ci es li k e c hr o ni c l y m p h o bl asti c
l e u k a e mi a (2 9 ) a n d a c ut e  m y el oi d l e u k a e mi a (3 0 ).  N e v ert h el ess, t h e
eff e ct of  At o o n c A L L h as n ot b e e n st u di e d.
T h er ef or e, gi v e n t h e b o d y of e vi d e n c e i n lit er at ur e t h at c A L L
c ells h a v e alt er ati o ns i n t h eir  mit o c h o n dri al a n d  m et a b oli c
f u n cti o n, t o g et h er  wit h e n c o ur a gi n g r es ults usi n g  At o i n ot h er
m ali g n a n ci es, t h e ai m of o ur st u d y  w as t o i n v esti g at e if  At o  m a y
b e eff e cti v e a g ai nst c A L L c ells as  w ell.M A T E RI A L S  A N D  M E T H O D S
C ell  C ult ur e,  Dr u g  Tr e at m e nt s,  C ell
Vi a bilit y, a n d  C ell  C o u nt s
T h e c hil d h o o d  A L L c ell li n e  R E H ( h ar b o uri n g a  T E L- A M L 1
f usi o n, is ol at e d aft er 1st r el a ps e)  w as ki n dl y pr o vi d e d b y  Dr.  Ti n o
S c h e n k fr o m t h e  U ni v ersit y  H os pit al of J e n a ( G er m a n y),  w hilst
S u p- B 1 5  w as p ur c h as e d fr o m  D S M Z ( G er m a n y). B ot h c ell li n es
w er e c ult ur e d i n st a n d ar d c o n diti o ns — R E H c ells i n  R P MI  wit h
1 0 % f o et al b o vi n e s e r u m ( F B S ) a n d 0. 5 %  P e ni cilli n –
Str e pt o m y ci n ( P e n/ Str e p), a n d S u p- B 1 5 ( h ar b o uri n g a B C R-
A B L 1 f usi o n, is ol at e d aft er 2 n d r el a ps e) i n I M D M  wit h 2 0 %
F B S a n d 0. 5 % P e n/ Str e p ( all fr o m P A N- Bi ot e c h,  G er m a n y).
At o v a q u o n e, I d ar u bi ci n, a n d Pr e d nis ol o n e ( C a y m a n  C h e mi c al,
U S A, E ur o p e a n  Di visi o n i n Est o ni a)  w er e diss ol v e d i n  D M S O
( P A N- Bi ot e c h,  G er m a n y) t o 2 0, 1 0, a n d 1 0 m M r es p e cti v el y. I C 5 0
v al u es  w er e d et er mi n e d f oll o wi n g dr u g tr e at m e nt of 3 d a ys a n d
ass ess m e nt of c ell vi a bilit y  wit h  M T T ass a y.  All e x p eri m e nts  w er e
p e rf o r m e d at l e a st i n bi ol o gi c al d u pli c at e s a n d t e c h ni c al
tri pli c at es.  C ell c o u nts  w er e d et er mi n e d usi n g L u n a II c ell
c o u nt er ( L o g os bi o, S o ut h  K or e a).
E st a bli s h m e nt  of  St a bl e  Pr e d ni s ol o n e -
R e si st a nt  C ell s
T o d e v el o p  P r e d ni s ol o n e- r esi st a nt s u b- cl o n e s of S u p- B 1 5
c ell s,  w e u s e d alt e r n ati n g c y cl e s of d r u g t r e at m e nt  wit h
i n cr e asi n g c o n c e ntr ati o ns of Pr e d nis ol o n e b y s m all i n cr e m e nts
f oll o w e d b y c ell e x p a nsi o n. I n bri ef, t h e I C5 0 c o n c e ntr ati o n of
Pr e d nis ol o n e f or S u p- B 1 5  w as d et er mi n e d, a n d c ells  w er e tr e at e d
wit h t his c o n c e ntr ati o n of 0. 0 0 2 m M f or 3 d a ys. S ur vi vi n g c ells
w er e c e ntrif u g e d t o eli mi n at e d e a d c ells, c ell d e bris, a n d a n y
r e m ai ni n g Pr e d nis ol o n e,  w as h e d  wit h  m e di u m, a n d l eft t o
r e c o v er a n d e x p a n d i n gr o wt h  m e di u m f or 3 – 4 d a ys.  T h es eM ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L Lc ells  w er e t h e n tr e at e d  wit h 1. 5 × I C 5 0 of Pr e d nis ol o n e f or a n ot h er
3 d a ys, t h e n c e ntrif u g e d,  w as h e d, a n d l eft i n gr o wt h  m e di u m t o
e x p a n d a g ai n.  T h e t hir d c y cl e us e d 2 × I C 5 0 of Pr e d nis ol o n e, a n d
e v er y f oll o wi n g c y cl e u s e d i n c r e m e nt s of 3 0 – 5 0 % hi g h e r
c o n c e ntr ati o n, c o m p ar e d t o t h e pr e vi o us c y cl e. E v er y f o ur t o
fi v e c y cl es Pr e d nis ol o n e  w as titr at e d t o d et er mi n e t h e s hift i n
I C5 0 c o m p ar e d t o t h e p ar e nt al S u p- B 1 5 c ells.  T h es e c y cl es of
t r e at m e nt  wit h i n c r e a s e d c o n c e nt r ati o n s of  P r e d ni s ol o n e
f oll o w e d b y c ell r e c o v er y a n d e x p a nsi o n ( > 1 5 c y cl es)  w er e
r e p e at e d u ntil  w e r e a c h e d a b o ut 1, 0 0 0 ti m e s r e si st a n c e
c o m p ar e d t o p ar e nt al S u p- B 1 5 c ells.
P ati e nt  S a m pl e s
B o n e  m arr o w as pir at es fr o m p ati e nts  w er e c oll e ct e d f or st a n d ar d
di a g n osis b y fl o w c yt o m etr y.  C ells fr o m t h e r e m ai ni n g s a m pl es
w e r e i s ol at e d u si n g  P a n c oll ( P A N- Bi ot e c h) f oll o wi n g t h e
i nstr u cti o ns b y t h e  m a n uf a ct ur er.  At l e ast 3 0 0, 0 0 0 c ells p er
w ell  w er e pl at e d f or  At o v a q u o n e tr e at m e nt, c ult ur e d f or 3 d a ys
a n d a n al ys e d  wit h t h e S e a h ors e  X F p I nstr u m e nt.  W h er e p ossi bl e,
3 0, 6 0, a n d 9 0 m M of  At o v a q u o n e  w er e t est e d. F or ass ess m e nt of
vi a bilit y a n d t h e eff e ct of  At o v a q u o n e a n d I d a r u bi ci n
c o m bi n ati o ns, p ati e nt s a m pl es  w er e s e e d e d at ~ 5 0, 0 0 0 c ells p er
w ell i n 9 6- w ell pl at es.  All e x p eri m e nts  wit h p ati e nt s a m pl es  w er e
p erf or m e d i n t e c h ni c al d u pli c at es a n d tri pli c at es  w h er e c ell
n u m b ers all o w e d. S a m pl es  w er e t a k e n aft er i nf or m e d c o ns e nt
b y t h e p ar e nts/ g u ar di a ns of t h e p ati e nts, a n d t h e st u d y  w as
a p pr o v e d b y t h e Et hi cs  C o m mitt e e at t h e  M e di c al  U ni v ersit y
of Pl o v di v.
S e a h or s e  X F p  A n al y si s  of  Mit o c h o n dri al
F u n cti o n
F or ass ess m e nt of  mit o c h o n dri al f u n cti o n  w e us e d S e a h ors e  X F p
a n al ys er a n d  Mit o Str ess  T est kit ( A gil e nt,  U S A). F or t his  Mit o
Str ess pr ot o c ol, t hr e e  mit o c h o n dri al i n hi bit ors ( all fr o m  C a y m a n
C h e mi c al,  U S A, E ur o p e a n  Di visi o n i n Est o ni a)  w er e i nj e ct e d
c o ns e c uti v el y o nt o t h e c ells — Oli g o m y ci n (i n hi bit or of t h e  A T P
S y nt h et as e) at 1 m M fi n al c o n c e ntr ati o n, F C C P (tri fl u or o m et h o x y
c ar b o n yl c y a ni d e p h e n yl h y dr a z o n e — a n u n c o u pl er of t h e E T C) at
2 m M fi n al c o n c e ntr ati o n a n d  R ot e n o n e (i n hi bit or of  C o m pl e x I of
t h e E T C) at 0. 5 m M fi n al c o n c e ntr ati o n.  T his all o w e d t h e
ass ess m e nt of s e v er al p ar a m et ers i n cl u di n g b as al a n d  m a xi m al
r es pir ati o n, s p ar e r es pir at or y c a p a cit y,  A T P l e v els, a n d ot h ers. B-
c ell  A L L c ells  w er e gr o w n i n 1 2- or 2 4- w ell pl at es  wit h or  wit h o ut
At o v a q u o n e f or 7 2 h.  C ells  w er e t h e n c e ntrif u g e d a n d  w as h e d
t wi c e  wit h S e a h ors e- c o m p ati bl e bi c ar b o n at e b uff er-fr e e  R P MI
( A p pli C h e m,  G er m a n y) s u p pl e m e nt e d  wit h P yr u v at e ( 1  m M)
wit h a dj ust e d fi n al p H of 7. 2 – 7. 4.  C ells  w er e t h e n c o u nt e d  wit h
L u n a II c ell c o u nt er ( L o g os Bi o, S o ut h  K or e a) a n d s e e d e d at 1 0 0 –
3 0 0, 0 0 0/ w ell i n S e a h ors e  mi cr o pl at es ( A gil e nt,  U S A),  w hi c h  w er e
pr e- c o at e d  wit h P ol y- D- L ysi n e at 1  m g/ ml f or 3 0  mi n. S e a h ors e
o x y g e n c o ns u m pti o n r at e ( O C R) d at a f or e a c h e x p eri m e nt  w as
n or m alis e d t o t ot al li v e c ells p er  w ell c o u nt e d  wit h L u n a II c ell
c o u nt er ( L o g os Bi o, S o ut h  K or e a) usi n g S e a h ors e  W a v e  D es kt o p
S oft w ar e v 2. 6. 0 ( A gil e nt,  U S A).  D at a a n al ysis  w as t h e n p erf or m e d
usi n g t h e  X F  Mit o Str ess  R e p ort  G e n er at or  wit hi n  W a v e
D es kt o p S oft w ar e.Fr o nti er s i n  O n c ol o g y |  w w w.fr o nti er si n. or g 3C ell  C y cl e a n d  A p o pt o si s  A s s a y s
C ell c y cl e a n al ysis a n d  A n n e xi n  V/ PI ass a y f or a p o pt osis  w er e
c arri e d o ut o n a  G u a v a ® M us e ® C ell  A n al ys er ( L u mi n e x,  U S A)
usi n g t h e r es p e cti v e st a n d ar d kits a n d pr ot o c ols o pti mis e d
b y L u mi n e x.
R N A - S e q u e n ci n g
R N A e xtr a cti o n fr o m c o ntr ol u ntr e at e d a n d  At o-tr e at e d ( 3 0 m M)
s a m pl es i n bi ol o gi c al tri pli c at es  w as c arri e d o ut o n d a y 3 aft er
tr e at m e nt fr o m ~ 1  milli o n p ell et e d c ells p er c o n diti o n  wit h  Qi a g e n
R N e as y kit ( Qi a g e n,  U S A) a c c or di n g t o t h e  m a n uf a ct ur er ’s
r e c o m m e n d ati o ns. I niti al s a m pl e c o n c e ntr ati o n a n d q u alit y  w as
ass ess e d b y  N a n o dr o p ( T h er m o,  U S A). S a m pl es  w er e t h e n s e nt t o
N o v o g e n e  U K f or f urt h er  Q C, r e v ers e tr a ns cri pti o n, li br ar y
pr e p ar ati o n, a n d s e q u e n ci n g. I n bri ef,  N E B N e xt ® Ultr a T M  R N A
Li br ar y Pr e p  Kit f or Ill u mi n a ® ( N E B,  U S A)  w as us e d f or li br ar y
pr e p ar ati o n  wit h  A M P ur e  X P b e a ds ( B e c k m a n  C o ult er, B e v erl y,
U S A) f or si z e s el e cti o n a n d P C R p uri fi c ati o n st e ps, b ot h p erf or m e d
as i nstr u ct e d b y t h e  m a n uf a ct ur ers. Fi n all y, s e q u e n ci n g  w as
p erf or m e d o n a n Ill u mi n a S e q u e n c er g e n er ati n g > 2 0 M p air- e n d
cl e a n r e a ds p er s a m pl e.
S y n er g y  T e sti n g
A n al ysis of dr u g c o m bi n ati o ns  w a s c arri e d o ut  wit h S y n er g y Fi n d er
(3 1 ).  T h e z er o i nt er a cti o n p ot e n c y ( ZI P)  m o d el (3 2 )  w as c h os e n as
t h e d ef a ult p ar a m et er i n S y n er g y Fi n d er (t o g et h er  wit h f o ur
p ar a m et er l o gisti c r e gr essi o n al g orit h m, L L 4, f or c ur v e fi tti n g) t o
c al c ul at e d ( d elt a) s c or es/s y n er g y s c or es f or t h e i nt er a cti o n b et w e e n
At o v a q u o n e a n d I d ar u bi ci n.  T h e r ef er e n c e p oi nt i n t h e ZI P  m o del is
z er o ( i.e. d = 0),  w hi c h i m pli es z er o i nt er a cti o n b et w e e n t h e t w o
dr u gs. S y n er g y s c or es l o w er t h a n z er o ( i.e. d < 0) i m pl y a li k el y
a nt a g o nisti c i nt er a cti o n ( d < − 1 0 is c o nsi d er e d  m ost li k el y
a nt a g o nisti c),  w hilst d > 0 s h o ws a d diti vit y or s y n er g y b et w e e n
t h e t w o t est e d dr u gs (d > 1 0  w o ul d b e i nt er pr et e d as  m ost li k el y
s y n er gisti c) (3 2 ).
St ati sti c al  A n al y si s
Se q u e n ci n g q u alit y c o ntr ol,  m a p pi n g, q u a nti fi c ati o n, a n d diff er e nti al
g e n e e x pr essi o n a n al ysis  w er e als o p erf or m e d b y  N o v o g e n e usi n g
HI S A T 2 s oft w ar e,  R P K M c al c ul ati o n f or e a c h g e n e,  D E S e q 2 a n d
E d g e R p ac k a g e i n  R t o g e n er at e lists  wit h diff er e nti all y e x pr ess e d
g e n es b et w e e n  At o v a q u o n e tr e at m e nt a n d c o ntr ol s a m pl es.
A dj ust e d p - v al u e (≤ 0. 0 5) a n d f ol d c h a n g e ( F C) of ≥ 1. 3 a n d ≤ − 1. 3
w er e us e d as t hr es h ol ds t o cr e at e t h e g e n e lists n ec ess ar y f or
d o w nstr e a m a n al ysis.  G e n e  O nt ol o g y ( G O) a n al ysis  w as c arri e d
o ut b y Bi n G O ( 3 3 ) i n C yt os c a pe S oft w ar e (3 4 ) w h er e st atisti c all y
si g nifi c a ntl y e nri c h e d n o d es ( p - ≤ 0. 0 5) h a v e b e e n c ol o ur- c o de d
( y ell o w f or 5 × 1 0− 2 t o d ar k or a n g e f or 5 × 1 0− 7 ).  G e n e s et
e nri c h m e nt a n al ysis ( G S E A)  w as p erf or m e d fr o m g e n er at e d lists
wit h diff er e nti all y e x pr ess e d g e n es as d es cri b e d a b o v e usi n g t h e
G S E A s oft w ar e b y t h e Br o a d I nstit ut e ( 3 5 ) (st a n d ar d s etti n gs of
1, 0 0 0 p er m ut ati o ns, per m ut ati o n t y p e — g e n e _s et, a n d  M ol e c ul ar
Si g n at ur e  D at a b as e g e n e s ets — H:  H all m ar k,  C 2:  C ur at e d g e n e s ets,
C 5: o nt ol o g y g e n e s ets,  C 6: o n c o g e ni c si g n at ur es g e n e s ets).  T h e
d ef a ult F D R c ut- off is 0. 2 5; h o w e v er, o nl y g e n e s ets  wit h F D R ≤ 0. 0 5
w er e pl ott e d.  Gr a p h P a d Pris m ( v. 8)  w as us e d f or fi g ur e pr e p ar ati o nM ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L La n d st atisti c al a n al ysis ( p ar a m etri c u n p air e d St u d e nt ’s t-t est f or
S e a h ors e a n d  M T T d at a a n d p air e d St u de nt ’s t-t est f or p ati e nt
s a m pl es’ st a n d ar d c ut- offs of p - ≤ 0. 0 5).R E S U L T S
At o v a q u o n e  D e m o n str at e s  A nti -
L e u k a e mi c  Pr o p erti e s I n  Vitr o T hr o u g h
I n hi biti o n  of  Mit o c h o n dri al  R e s pir ati o n
T he a nti- pr olif er ati v e eff e ct of  At o v a q u o n e o n  R E H c ells  w as
i n v e sti g at e d fi r st.  W e f o u n d t h at at I C 5 0 c o n c e nt r ati o n
(S u p pl e m e nt ar y Fi g ur e 1 A )  At o v a q u o n e e x erts its a nti-l e u k a e mi c
eff e ct t hr o u g h b ot h d e c el er ati o n of t h e c ell c y cl e ( 5 3. 4 ± 7. 7 % i n  G 1-
p h as e i n c o ntr ol c ells vs 6 7. 6 ± 3. 5 % i n  At o-tr e at e d c ells, p = 0. 0 4 4,
as  w ell as 2 9. 6 ± 6. 3 % of c o ntr ol c ells i n S- p h as e vs 1 9. 3 ± 1. 7 % i n
At o-tr e at e d c ells, p = 0. 0 5, S u p pl e m e nt ar y Fi g ur e 1 B ).  At o als o
i n cr e as e d t h e n u m b er of a p o pt oti c c ells ( 1 9. 8 ± 2. 9 % a p o pt oti c c ells
i n c o ntr ol vs 3 0. 2  ± 6. 6 % i n  At o-tr e at e d c ells, p = 0. 0 0 5,
S u p pl e m e nt ar y Fi g ur e 1 C ). I n or d er t o el u ci d at e t h e p ot e nti al
m e c h a nis m of a cti o n of  At o.  w e e x a mi n e d t h e  mit o c h o n dri al
f u n cti o n of t h e c ells f oll o wi n g tr e at m e nt  wit h t h e dr u g f or t hr e e
d a ys ( Fi g ur e 1 A ).  W e f o u n d t h at  At o tr e at m e nt l e d t o a ~t w o-f ol d
r e d ucti o n of b as al r es pir ati o n (fr o m 4 0 7. 6 ± 4 8. 8 t o 2 1 9. 4 ± 5 3. 9, p <
0. 0 0 0 1) a n d ~ 3. 7-f ol d d e cr e as e i n  m a xi m al r es pir ati o n (fr o m
8 1 3. 8 ± 9 3. 1 t o 2 2 0. 2 ± 1 1 6, p < 0. 0 0 0 1). It n e arl y c o m pl et el y
a b olis h e d s p ar e r es pir at or y c a p a c it y (fr o m 4 0 6. 2 ± 5 2. 1 t o 0. 8 ± 6 3. 6,
p < 0. 0 0 0 1) a n d d e cr e as e d  A T P pr o d u cti o n b y  m or e t h a n h alf (fr o m
3 4 3  ± 3 2. 3 t o 1 3 7. 6  ± 7 9. 6, p = 0. 0 0 0 2) ( Fi g u r e 1 B a n d
S u p pl e m e nt ar y  T a bl e 1 ).
R N A-s e q ( Fi g ur es 1 C,  D , S u p pl e m e nt ar y Fi g ur es 2 a n d 3 , a n d
S u p pl e m e nt ar y  T a bl e 2 ) ai mi n g t o el u ci d at e t h e eff e ct of  At o o n
R E H c ells s h o w e d t h at t his dr u g c h a n g e d t h e e x pr essi o n of n e arl y
2, 0 0 0 g e n es c o m p ar e d t o u ntr e at e d c ells ( wit h c ut- offs of a dj ust e d p -
v al u e < 0. 0 5, F C > 1. 3).  G e n e o nt ol o g y ( G O) a n al ysis r e v e al e d
e nri c h m e nt f or c ell  m et a b oli c pr o c ess es ( Fi g ur e 1 C ), a p o pt osis,
c ell c y cl e arr est, a n d a s m all cl ust er of o xi d ati v e str ess g e n es
(S u p pl e m e nt ar y Fi g ur es 2 A – C ),  w hi c h is a n ot h er c o nfi r m ati o n
of t h e p h e n ot y pi c eff e cts  w e o bs er v e d. F urt h er  G e n e S et E nri c h m e nt
A n al ysis ( G S E A) de m o nstr at e d — u pr e g ul ati o n of t h e p 5 3 p at h w a y,
d o w nr e g ul ati o n of E 2 F, a n d  G 2 M c h e c k p oi nt ( b ot h r el at e d t o c ell
c y cl e c o ntr ol), a n d of h y p o xi a g e n e s ets ( Fi g ur e 1 D ).  W e f urt h er
f o u n d t h at  At o tr e at m e nt  m a y e n h a n c e f att y a ci d  m et a b olis m
a n d, i nt er esti n gl y, d o w nr e g ul at e  R N A  m et a b oli c pr o c ess es
(S u p pl e m e nt ar y Fi g ur e 3 ).
A n ot h er B- c ell pr e c urs or c A L L c ell li n e — S u p- B 1 5  w as a n al ys e d
as  w ell.  W e als o  m a d e us e of a  Gl u c o c orti c oi d-r esist a nt s u b- cl o n e of
S u p- B 1 5 r ef err e d t o as “S u p- P R ” t h at  w as est a blis h e d i n o ur
l a b or at or y (M et h o ds a n d S u p pl e m e nt a r y Fi g u r e 1 D ).  W e
o bs er v e d t h at  At o h a d si mil ar I C 5 0 v al u es as i n  R E H c ells ( ~ 3 0
m M, S u p pl e m e nt ar y Fi g ur e 1 E ) a n d eli cit e d v er y si mil ar c h a n g es i n
mit o c h o n dri al r es pir ati o n a n d  A T P pr o d u cti o n i n b ot h S u p- B 1 5
a n d S u p- P R c ells ( Fi g ur es 2 A,  B ).  Of n ot e,  G C-r esist a n c e of ar o u n d
1, 0 0 0 ti m es di d n ot c h a n g e t h e r es p o ns e t o  At o, a n d  w e f o u n d
si g nifi c a nt r e d u cti o n of b as al a n d  m a x i m al r es pir ati o n, as  w ell as of
A T P pr o d u cti o n i n S u p- P R c ells ( S u p pl e m e nt ar y  T a bl e 3 a n d
Fi g ur e 2 B ).Fr o nti er s i n  O n c ol o g y |  w w w.fr o nti er si n. or g 4At o v a q u o n e  E n h a n c e s t h e  Eff e ct  of
St a n d ar d  C h e m ot h er a p e uti c s a n d
R e s e n siti s e s  R e si st a nt  C ell s t o
Gl u c o c orti c oi d s
We als o i n v esti g at e d if  At o  m a y e n h a n c e t h e a cti o n of st a n d ar d
c h e m ot h er a p e uti cs k n o w n t o aff e ct diff er e nt as p e cts of c ell
m et a b olis m.  T her e b y,  w e e x a mi ne d c o m bi n ati o ns  wit h s e ver al
c h e m ot h er a p e uti cs  w hi c h ar e p art of t h e st a n d ar d tr e at m e nt
r e gi m e n s u c h as  M et h otr e x at e (t ar g eti n g f oli c a ci d  m et a b olis m),
I d ar u bi ci n (t o p ois o m er as e II i n hi bit or a n d i n hi bit or of c o m pl e x I of
t h e E T C), a n d Pr e d nis ol o n e (t ar g eti n g gl y c ol ysis).  W e f o u n d
m ar k e d s y n er gisti c eff e ct ( ZI P s y n er g y s c or e of 2 4. 4) i n  R E H c ells
o nl y  w h e n  At o  w as i n c o m bi n ati o n  wit h I d ar u bi ci n ( Fi g ur e 3 A a n d
S u p pl e m e nt ar y Fi g ur e 1 F f or I C5 0 v al u es) a n d n ot i n a n y of t h e
ot h er t w o c o m bi n ati o ns ( d at a n ot s h o w n). F urt h er m or e, t his
s y n er g y h a d a  m ar k e d eff e ct o n c ell pr olif er ati o n as  w ell (fr o m
1. 9 6 ± 0. 4 × 1 0 5 li v e c o ntr ol c ells o n d a y 3 t o 0. 8 3 ± 0. 1 9 × 1 05 li v e
c ells tr e at e d  wit h  At o a n d I d ar u bi ci n, p < 0. 0 0 0 1, Fi g ur e 3 B a n d
S u p pl e m e nt ar y  T a bl e 4 ).  W e als o i n v esti g at e d if t his c o m bi n ati o n
w o ul d  w or k i n S u p- B 1 5 a n d S u p- P R c ells ( S u p pl e m e nt ar y Fi g ur e
1 F f or I C5 0 v al u es). I nt er esti n gl y,  w hilst t h e t w o dr u gs d e m o nstr at e d
o nl y a d diti v e eff e ct o n S u p- B 1 5 c ells ( Fi g ur e 3 C , s y n er g y s c or e of
3. 6), S u p- P R pr o v e d  m or e s e nsiti v e t o t his d o u bl e tr e at m e nt  wit h a
s y n er g y s c or e of 1 6. 7 (Fi g ur e 3 C ).
Gl u c o c orti c oi d ( G C) r esist a n c e is b eli e v e d t o b e o n e of t h e
m aj or c a us es of r el a ps e i n t h e cli ni c. Si n c e  w e f o u n d t h at S u p- P R
c ells r e m ai n s e nsiti v e t o  At o,  w e t h e n i n v esti g at e d if  At o c a n r e-
s e nsitis e t h es e c ells t o Pr e d nis ol o n e.  T h er ef or e,  w e e x a mi n e d
At o- Pr e d d o u bl e c o m bi n ati o n i n S u p- B 1 5 a n d S u p- P R c ells.
W h at  w e dis c o v er e d  w as t h at  w hilst t his c o m bi n ati o n i n t h e
p ar e nt al S u p- B 1 5 c ells  m a y e v e n pr o v e t o b e c o u nt er pr o d u cti v e
( a nt a g o nisti c  ZI P s c or e of − 1 4. 2 — Fi g u r e 3 D ), t his tr e at m e nt h a d
a n a d diti v e eff e ct o n S u p- P R c ells (s c or e of 7 — Fi g u r e 3 D ).
V ali d ati o n  of t h e  Eff e ct  of  At o v a q u o n e i n
P ati e nt  S a m pl e s
L astl y,  w e att e m pt e d t o v ali d at e o ur fi n di n gs i n a s m all n u m b er
of p ati e nt s a m pl es a v ail a bl e fr o m t h e  O n c o h a e m at ol o g y  U nit at t h e
U ni v ersit y  Cli ni c of P a e di atri cs ( Fi g ur es 4 A – D a n d S u p pl e m e nt ar y
T a bl e 5 ). I m p ort a ntl y,  w e f o u n d t h at  At o is c a p a bl e of r e d u ci n g
gr o wt h i n pri m ar y l y m p h o bl asts at 3 0 m M c o n c e ntr ati o ns ( Fi g ur e
4 A ),  w hi c h ar e l o w er t h a n t h e  m a xi m u m ac hi e v a bl e pl as m a l e v els i n
vi v o (s e e Disc ussi o n ). F urt h er m or e,  w e v ali d at e d t h at  At o is c a p a bl e
of t ar g eti n g  mit o c h o n dri al r es pir ati o n a n d  A T P pr o d u cti o n i n
p ati e nt s a m pl es ( Fi g ur es 4 B,  C a n d S u p pl e m e nt ar y  T a bl e 6 ).
L astl y,  w e i n v esti g at e d t h e eff e ct of c o m bi ni n g  At o a n d I d ar u bi ci n
i n t h es e s a m pl es. I nt er esti n gl y,  w e f o u n d t h at t his c o m bi n ati o n
eli cits a  m or e v ari a bl e r es p o ns e b et w e e n t h e s a m pl es r a n gi n g fr o m
a nt a g o nisti c (i n o n e s a m pl e) t o a d diti v e (i n t w o s a m pl es), a n d
s y n er gisti c (i n o n e s a m pl e) (Fi g ur e 4 D ).DI S C U S SI O N
I n s u m m ar y,  w e h a v e i n v esti g at e d t h e a nti- pr olif er ati v e a cti vit y
of  At o v a q u o n e o n t w o est a blis h e d B- c ell pr e c urs or c A L L c ellM ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L Lli n es— R E H a n d S u p- B 1 5, as  w ell as o n a Pr e d nis ol o n e-r esist a nt
s u b- cl o n e of S u p- B 1 5.  W e f o u n d t h at  At o eli cit e d a v er y si mil ar
eff e ct o n  mit o c h o n dri al r es pir ati o n a n d  A T P pr o d u cti o n i n all
t hr e e c ell li n es at c o n c e ntr ati o ns of ~ 3 0 m M.  T h es e fi n di n gs ar e i n
li n e  wit h pr e vi o us i n vitr o st u di es [ 1 0 m M i n br e ast c a n c er ( 2 6 )
a n d c er vi c al c a n c er c ells ( 3 6 ), 3 0 m M i n c ol or e ct al, p h ar y n g e al
a n d l u n g c a n c er c ell li n es ( 2 7 , 3 7 ), ~ 1 5– 5 0 m M f or gli o bl ast o m a
c ells ( 3 8 ), 2 0 m M i n r eti n o bl ast o m a ( 2 8 ) a n d t h yr oi d c a n c er c ells
(3 9 )]. I n p arti c ul ar,  At o r e d u c e d t h e l e v els of b as al a n d  m a xi m alFr o nti er s i n  O n c ol o g y |  w w w.fr o nti er si n. or g 5r es pir ati o n, d e cr e as e d t h e r es pir at or y c a p a cit y of t h e c ells a n d
A T P pr o d u cti o n as  m e as ur e d b y t h e S e a h ors e  Mit o Str ess t est.
E v e n if  w e c o ul d c arr y o ut t h es e e x p eri m e nts o n a li mit e d
n u m b er of p ati e nt s a m pl es,  w e o bs er v e d t h at  At o c a n i n d u c e
si mil a r c h a n g e s of  mit o c h o n d ri al r e s pi r ati o n i n p ri m a r y
l y m p h o bl asts as  w ell.
G S E A a n d  G O a n al ys es i n  R E H c ells c o n fi r m e d s o m e of t h e
p h e n ot y pi c o bs e r v ati o ns i n o u r st u d y — alt e r ati o n s i n c ell
m et a b oli s m, i n d u cti o n of a p o p t o si s, a n d c ell c y cl e a r r e stA C
B
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FI G U R E 1 |  At o v a q u o n e tr e at m e nt t ar g et s c ell  mit h o c h o n dri al r e s pir ati o n a n d a cti v at e s a p o pt o si s a n d c ell c y cl e arr e st i n  R E H c ell s.  R E H c ell s  w er e tr e at e d  wit h I C5 0
c o n c e ntr ati o n s of  At o v a q u o n e ( 3 0 µ M) f or 3 d a y s a n d c o m p ar e d t o u ntr e at e d c o ntr ol c ell s. ( A) T h eir  mit o c h o n dri al f u n cti o n  w a s a n al y s e d  wit h  S e a h or s e X F p
A n al y s er I n str u m e nt u si n g t h e  Mit o  Str e s s T e st ( A gil e nt,  U S A). ( B) T h e r e s ult s of t h e t e st s h o w e d r e d u cti o n i n b a s al a n d  m a xi m al r e s pir ati o n, s p ar e r e s pir at or y
c a p a cit y a n d  A T P pr o d u cti o n aft er tr e at m e nt  wit h  At o. ( C) C o ntr ol a n d  At o-tr e at e d  R E H c ell s  w er e c oll e ct e d o n d a y 3 a n d  R N A- s e q u e n ci n g  w a s c arri e d o ut.  G e n e
o nt ol o g y ( G O) a n al y si s  wit h  Bi n G O i n  C yt o s c a p e s h o w e d a cl u st er of st ati sti c all y si g ni fi c a ntl y r e pr e s e nt e d n o d e s r el at e d t o  m et a b oli c pr o c e s s e s a s s h o w n
( st ati sti c all y n ot si g nifi c a nt n o d e s  w er e r e m o v e d fr o m t h e cl u st er).  S c al e b ar ( y ell o w- or a n g e) d e pi ct s p - v al u e s a s a n n ot at e d. ( D) G e n e s et e nri c h m e nt a n al y si s ( G S E A)
w a s al s o p erf or m e d  wit h t h e  G S E A s oft w ar e b y t h e  Br o a d I n stit ut e. T h e a n al y si s d e m o n str at e s str o n g st ati sti c all y si g ni fi c a nt ( F D R q- v al u e  < 0. 0 5) e nri c h m e nt f or t h e
s h o w n g e n e s et s. Err or b ar s r e pr e s e nt  m e a n  wit h  S D fr o m bi ol o gi c al tri pli c at e s i n t e c h ni c al d u pli c at e s. *** p < 0. 0 0 0 5,  St u d e nt ’s t-t e st.  N E S, n or m ali s e d e nri c h m e nt
s c or e; F D R, f al s e di s c o v er y r at e q- v al u e.M ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L L(Fi g u r e 1 a n d S u p pl e m e nt a r y Fi g u r e 2 ), a n d p oi nt e d t o ot h er
i nt er esti n g c o n c o mit a nt c h a n g es t h at  m a y b e d u e t o  At o. S e v er al
p a p ers fr o m t h e p ast 5 y e ars h a v e i n v esti g at e d t h e a nti- c a n c er
eff e ct of  At o.  M ost of t h e m h a v e f o c uss e d o n i n hi biti o n of
O x P h o s,  w hi c h  w e c o n fi r m  h e r ei n a s  w ell,  w hil st t w o
p u bli c ati o ns s h o w t h at  At o  m a y  w or k t hr o u g h t ar g eti n g t h e
A K T – m T O R p at h w a y ( 2 8 ).  T h e i nt er pl a y b et w e e n  m T O R
c o m pl e x 1 ( m T O R C 1) a n d  mit o c h o n dri al f u n cti o n a n d c ell
m et a b olis m is  w ell- d o c u m e nt e d ( 4 0 ).  A cti v ati o n of t h e  A K T–
m T O R p at h w a y,  w hi c h is alt er e d i n u p t o o n e t hir d of c hil dr e n
wit h  T- A L L ( 4 1 ),  m a y l e a d t o c o nsi d er a bl e c h a n g es i n c ell
m et a b olis m a n d u pr e g ul ati o n of gl y c ol ysis ( 4 , 4 2 ). I n v esti g ati n g
t h e p ot e nti al eff e ct of  At o o n t his p at h w a y  w as b e y o n d t h e s c o p e ofFr o nti er s i n  O n c ol o g y |  w w w.fr o nti er si n. or g 6o ur st u d y.  N e v ert h el ess, o n e of t h e  m ost d o w nr e g ul at e d g e n es  w e
f o u n d (l o g 2 = − 2. 1, a dj ust e d p - v al u e = 0. 0 0 1 8) is P T E N a n d  G S E A
fr o m o ur  R N A-s e q s h o w e d si g nifi c a nt a n d str o n g d o w nr e g ul ati o n
of  m T O R C 1 g e n es ( S u p pl e m e nt ar y  T a bl e 2 a n d S u p pl e m e nt ar y
Fi g ur e 3 ).  Of n ot e, t h er e ar e li n ks b et w e e n  m T O R C 1 a n d t h e  M Y C
o n c o pr ot ei n, as  w ell as b et w e e n o v er e x pr essi o n of M Y C a n d
s hifts i n c A L L  m et a b olis m (9 ).  T h er ef or e, it is n ot e w ort h y t h at
o ur  G S E A als o r e v e al e d d o w nr e g ul ati o n of  M Y C t ar g ets i n  At o-
tr e at e d c ells (S u p pl e m e nt ar y Fi g ur e 3 ).
At o h as b e e n s h o w n t o all e vi at e h y p o xi a a n d s e nsitis e c a n c er
c ell s t o r a di ot h e r a p y ( 2 7 ). O u r G S E A a n al y sis hi g hli g ht s
alt er ati o ns of h y p o xi a as o n e of t h e t o p hits a n d i n d e e d  w e s e e
d o w nr e g ul ati o n of t h e dir e ct  HI F 1- a t ar g et V E G F a aft er
tr e at m e nt (S u p pl e m e nt a r y  T a bl e 2 ).  T h er e is e vi d e n c e t h at
r a di ati o n t h er a p y f or hi g h-ris k  T- A L L p ati e nts  m a y r e d u c e
r at es of r el a ps e (4 3 ).  Gi v e n t h at h y p o xi a is a  m aj or f a ct or f or
t h e effi c a c y of r a di ati o n t h er a p y, t h at  At o r e d u c es h y p o xi a i n pr e-
cli ni c al  m o d els ( 2 7 , 4 4 ) a n d i n o ur g e n e s et e nri c h m e nt a n al ysis
(Fi g u r e 1 ),  At o tr e at m e nt  m a y b e  w ort h y of f urt h er i n v esti g ati o n
i n t his cli ni c al c o nt e xt of B- c ell c A L L t o o.
T h e c o m bi n ati o n of  At o  wit h I d ar u bi ci n is a n ot h er i nt er esti n g
as p e ct of o ur st u d y.  T h er e is a n i n d e p e n d e nt c o n fi r m ati o n of t h e
s y n er g y b et w e e n  At o a n d a nt hr a c y cli ns c o mi n g fr o m  w or k o n
t h yr oi d c a n c er c ells. L v a n d c oll e a g u es f o u n d t h at  At o a n d
D o x or u bi ci n ar e a n eff e cti v e str at e g y  w or ki n g t hr o u g h E T C
a n d c o ns e q u e nt S T A T 3 i n hi biti o n ( 3 9 ).  Of n ot e,  At o a n d
I d ar u bi ci n  w er e  m ost eff e cti v e i n  R E H c ells a n d S u p- P R c ells,
b ot h of  w hi c h ar e pr olif er ati n g f ast er t h a n S u p- B 1 5.  T h er ef or e, it
m a y b e i nt er esti n g t o t est t his c o m bi n ati o n o n  m at c h e d p ati e nt
s a m pl es at di a g n osis a n d r el a ps e, b ut t his is b e y o n d t h e s c o p e of
o ur c urr e nt  w or k.
G C-r esist a n c e is b eli e v e d t o b e t h e  m ai n c a us e of dr u g-f ail ur e
a n d r el a ps e i n c A L L ( 4 5 ).  T h er ef or e, it  w as i nt er esti n g t o fi n d t h at
S u p- P R c ells r e m ai n s e nsiti v e t o  At o a n d t h at t h er e  w as a n a d diti v e
eff e ct of  At o a n d Pr e d nis ol o n e i n t his  G C-r esist a nt li n e, b ut n ot i n
t h e p ar e nt al c ells. I n v esti g ati n g t h e  m ol e c ul ar  m e c h a nis ms of
r esist a n c e (e. g. w h y S u p- P R c ells h a v e si g ni fi c a ntl y l o w er o x y g e n
c o ns u m pti o n r at es t h a n S u p- B 1 5 c ells — Fi g ur e 2 ) a n d of r e-
s e nsitis ati o n t o Pr e d nis ol o n e b y  At o  w as a n ot h er i m p ort a nt
as p e ct  w hi c h f ell o ut of t h e s c o p e of o ur st u d y.  H o w e v er, t h e
eff e cti v e n ess of  At o al o n e a n d i n c o m bi n ati o n  wit h I d ar u bi ci n or
Pr e d nis ol o n e i n  G C-r esist a nt c ell s is  w ort h y of f urt h er pr e- cli ni c al
i n v esti g ati o ns  wit h  m at c h e d s a m pl es a n d  m a y a d d a n ot h er c o nt e xt
t o a p ot e nti al cli ni c al tri al.
I m p ort a ntl y, t h er e ar e s e v er al k e y p oi nts r el at e d t o t h e p ati e nt
s a m pl es’ d at a a n d t h e p ot e nti al cli ni c al a p pli c a bilit y of t his st u d y
t h at n e e d t o b e a d dr ess e d.  D u e t o t h e s m all n u m b er of a v ail a bl e
p ati e nt s a m pl es,  w hi c h all b el o n g t o t h e  m ost c o m m o n t y p e of
c A L L a n d its  m ost fr e q u e nt  m ol e c ul ar s u bt y p e, o n e of t h e  m ai n
li mit ati o ns of o ur  w or k is t h e l a c k of d e pt h a n d r e pr es e nt ati vit y
of diff er e nt e ntiti es  wit hi n t his h et er o g e n e o us dis e as e. E v e n
t h o u g h t h e e x p eri m e nt al d at a  wit h t h es e f o ur p ati e nt s a m pl es
c a n n ot b e o v er-i nt er pr et e d a n d dir e ctl y tr a nsl at e d t o t h e cli ni c,
w e s h o w as a pr o of- of- c o n c e pt t h at  At o c a n hit its t ar g et i n
pri m ar y l y m p h o bl asts as  w ell.  W e o bs er v e si g ni fi c a nt d e cr e as e i n
mit o c h o n dri al r es pir ati o n a n d  A T P pr o d u cti o n ( Fi g u r e 4 B a n dA
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FI G U R E 2 |  At o v a q u o n e d e cr e a s e s  mit o c h o n dri al r e s pir ati o n a n d  A T P
pr o d u cti o n i n  S u p- B 1 5 c ell s a n d  Pr e d ni s ol o n e-r e si st a nt  S u p- P R c ell s.  S u p-
B 1 5 a n d  S u p- P R c ell s i n bi ol o gi c al d u pli c at e s  w er e tr e at e d  wit h 3 0 µ M of  At o
f or 3 d a y s a n d c o m p ar e d t o c o ntr ol u ntr e at e d c ell s. ( A) S u p- B 1 5 c ell s a n d
S u p- P R c ell s  w er e a s s a y e d  wit h  Mit o  Str e s s T e st o n  S e a h or s e X F p  A n al y s er
( A gil e nt,  U S A) a n d ( B) w er e a n al y s e d f or c h a n g e s i n  mit o c h o n dri al r e s pir ati o n
a n d  A T P pr o d u cti o n. Err or b ar s r e pr e s e nt  m e a n  wit h  S D fr o m bi ol o gi c al
d u pli c at e s i n t e c h ni c al d u pli c at e s. * p ≤ 0. 0 5, ** p ≤ 0. 0 0 5, *** p < 0. 0 0 0 5,
St u d e nt ’s t-t e st.M ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L LS u p pl e m e nt a r y  T a bl e 6 ), si mil arl y t o  w h at  w e h a v e i n  R E H, S u p-
B 1 5, a n d S u p- P R c ells.  N e v ert h el ess, t h e eff e ct of  At o o n c ell
vi a bilit y i n t h e p ati e nt s a m pl es ( Fi g u r e 4 A ) is n ot as pr o mi n e nt
as i n t h e c ell li n es.  T his  m o d est d e cr e as e i n c ell pr olif er ati o n,
h o w e v er,  m a y b e d u e t o eit h er s u b- o pti m al c o n c e ntr ati o ns of  At o
or t o t h e v er y sl o w c ell di visi o n of c ult ur e d pri m ar y c ells,  w hi c h
w o ul d n ot all o w f or t h e d et e cti o n of p ot e nti al c ell c y cl e arr est ( as
s e e n i n t h e f ast pr olif er ati n g  R E H c ells) a n d  w o ul d als o a c c o u nt
f or t h e l o w  O C R r e a di n gs es p e ci all y aft er  At o tr e at m e nt.  W e als o
f o u n d t h at t h e c o m bi n ati o n of  At o a n d I d ar u bi ci n i n p ati e nt
s a m pl es eli cits a r a n g e of r es p o ns es — fr o m a nt a g o nisti c t o
s y n er gisti c. B esi d es p ot e nti al diff er e n c es i n pr olif er ati o n r at es
e x vi v o ,  w hi c h  m a y a c c o u nt f or t h e l a c k of u nif or mit y i n t h e
r es p o ns e t o  At o a n d I d ar u bi ci n, t h e s m all n u m b er of p ati e nt
s a m pl es d o es n ot all o w f or a n y s p e c ul ati o ns ot h er t h a n t h at t h er e
m a y b e u ni d e nti fi e d  m ol e c ul ar a n d/ or c yt o g e n eti c f a ct ors  w hi c h
m a y d et er mi n e eit h er a d v a nt a g e o us or a d v ers e r es ults of t h e
d o u bl e t r e at m e nts.  T h er ef or e, a l ar g er c o h ort of p ati e nts
i n cl u di n g r el a ps e d s a m pl es  m a y b e  w ort h t esti n g.Fr o nti er s i n  O n c ol o g y |  w w w.fr o nti er si n. or g 7L astl y, t h e I C 5 0 c o n c e ntr ati o n  w e f o u n d f or o ur c ell li n es of 3 0
m M ( ~ 1 1 u g/ ml) ( S u p pl e m e nt a r y Fi g u r es 1 A,  E ) a n d t h e
c o n c e ntr ati o ns of  m a xi m u m 9 0 m M ( ~ 3 3 u g/ ml) t h at w e
m a n a g e d t o t est o n s o m e of t h e p ati e nt s a m pl es ar e  wit hi n t h e
cli ni c all y r e c or d e d l e v els f or  At o.  T h e st e a d y-st at e pl as m a
c o n c e ntr ati o n i n c hil dr e n a c hi e v e d b y d ail y a d mi nistr ati o n of
3 0  m g/ k g f or 1 2 d a ys is 3 7. 1 ± 1 0. 9 u g/ ml ( as d es cri b e d i n t h e
pr es cri bi n g i nf or m ati o n f or  M e pr o n ® ).  Ot h er lit er at ur e d at a
s u g g e st s si mil a r v al u e s — C m a x a n d  C mi n of r e s p e cti v el y
4 0. 5 ± 1 2. 2 a n d 3 4. 0 ± 1 1. 7 u g/ ml ( of 3 0  m g/ k g d ail y) ( 4 6 ).
F urt h er m or e, t h er e is a n i nt er esti n g fi n di n g c o mi n g fr o m a
r etr os p e cti v e st u d y of o v er 2 0 0 p ati e nts  wit h  A M L  w h o h a d
u n d er g o n e b o n e  m arr o w tr a ns pl a nt ati o n.  W h at  Xi a n g et al.
f o u n d  w as t h at a d mi nistr ati o n of  At o f or n e arl y t w o  m o nt hs as
a p art of st a n d ar d a nti-i nf e cti o n pr o p h yl a xis l e d t o si g ni fi c a nt
r e d u cti o n of r el a ps e r at es ( 1 3 vs 2 3 %, p = 0. 0 3 9) ( 3 0 ).  T h er ef or e,
c o nsi d eri n g t h e n u m b er of r o b ust pr e- cli ni c al st u di es i n ot h er
c a n c ers, t h e g o o d s af et y d at a f or  At o a n d t h e cl e ar eff e ct o n
pr olif er ati o n d u e t o E T C i n hi biti o n, it is t e m pti n g t o s p e c ul at eA
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FI G U R E 3 |  C o m bi n ati o n of  At o v a q u o n e  wit h st a n d ar d c h e m ot h er a p e uti c s pr o v e s eff e cti v e i n  R E H  Pr e d ni s ol o n e r e si st a nt  S u p- P R c ell s. ( A) R E H c ell s a n d ( C) S u p-
B 1 5 a n d  S u p- P R c ell s  w er e tr e at e d  wit h c o m bi n ati o n of I C 5 0 a n d I C 2 5 c o n c e ntr ati o n s of  At o v a q u o n e a n d I d ar u bi ci n i n tri pli c at e s f or t hr e e d a y s a n d a s s e s s e d b y
M T T t e st. T h e r e s ulti n g c ell vi a bilit y  m atri x  w a s t e st e d b y  S y n er g y Fi n d er. T h e d at a s h o w  % i n hi biti o n b a s e d o n p er c e nt a g e vi a bl e c ell s (l eft) a n d t h e c al c ul at e d
s y n er g y s c or e (ri g ht). ( B) C ell gr o wt h of  R E H c ell s tr e at e d a s s h o w n  w a s a s s e s s e d b y c ell c o u nti n g  wit h L u n a II  C ell  C o u nt er ( L o g o s Bi o,  S o ut h  K or e a).  C ell n u m b er s
w er e pl ott e d a s l a b ell e d i n t h e fi g ur e. Err or b ar s r e pr e s e nt  S D of t h e  m e a n f or  > 6 s e p ar at e c o u nt s fr o m tri pli c at e s. p- v al u e s  w er e c al c ul at e d  wit h,  St u d e nt ’s t-t e st. ( D)
S u p- B 1 5 a n d  S u p- P R c ell s  w er e tr e at e d  wit h I C 5 0 a n d I C 2 5 c o n c e ntr ati o n s of  At o v a q u o n e a n d  Pr e d ni s ol o n e a s si n gl e dr u g s a n d i n c o m bi n ati o n s. Tri pli c at e s  w er e
a n al y s e d o n d a y 3 b y  M T T a n d s y n er g y s c or e s  w er e c al c ul at e d b y  S y n er g y Fi n d er a s d e s cri b e d a b o v e.M ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L Lt h at  At o  w o ul d b e  w ort h y of f urt h er p r e- cli ni c al i n vi v o
i n v esti g ati o n a n d p er h a ps cli ni c al tri als as t h e o n g oi n g o n e o n
At o a n d r a di ati o n t h er a p y ( N C T 0 2 6 2 8 0 8 0).
I n c o n cl usi o n,  w e pr es e nt n o v el d at a d e m o nstr ati n g t h e a nti-
l e u k a e mi c eff e ct of  At o v a q u o n e, t h e  m e c h a nis m of a cti o n of t h e
dr u g a n d t h e c o n c o mit a nt g e n e e x pr essi o n c h a n g es t h at  m a y
u n d er pi n t h e p h e n ot y pi c c h a n g es o bs er v e d. F urt h er m or e, o ur
r es ults s u g g est t h at t his F D A- a p pr o v e d E T C i n hi bit or  m a y h a v e
a d diti v e or s y n er gisti c eff e ct t o g et h er  wit h I d ar u bi ci n.  G C-
r esist a nt c ells  m a y b e r e-s e nsitis e d t o  Pr e d nis ol o n e  w h e n
tr e at e d  wit h  At o v a q u o n e.  T h er ef or e, t h e fi n di n gs of t his st u d y
m a y pr es e nt a pr o misi n g n e w t h er a p e uti c a p pr o a c h t ar g eti n g c ell
m et a b olis m,  w hi c h  m a y b e  w ort h y of f urt h er i n v esti g ati o n.Fr o nti er s i n  O n c ol o g y |  w w w.fr o nti er si n. or g 8D A T A  A V AI L A BI LI T Y  S T A T E M E N T
T h e ori gi n al c o ntri b uti o ns pr es e nt e d i n t h e st u d y ar e p u bli cl y
a v ail a bl e.  T his d at a c a n b e f o u n d h er e: htt ps:// w w w. n c bi. nl m. ni h.
g o v/ g e o/ q u er y/ a c c. c gi? a c c = G S E 1 6 1 9 5 9.E T HI C S  S T A T E M E N T
T h e st u di es i n v ol vi n g h u m a n p arti ci p a nts  w er e r e vi e w e d a n d
a p pr o v e d b y t h e Et hi cs c o m mitt e e at  M e di c al  U ni v ersit y of
Pl o v di v.  Writt e n i nf or m e d c o ns e nt t o p arti ci p at e i n t his st u d y




FI G U R E 4 |  At o v a q u o n e s h o w s effi c a c y i n pri m ar y c A L L l y m p h o bl a st s. ( A) I s ol at e d p ati e nt c ell s  w er e c ult ur e d f or 3 d a y s  wit h 3 0 m M  At o v a q u o n e, a n d c ell vi a bilit y
w a s a s s e s s e d b y  M T T a s s a y.  P er c e nt a g e li v e c ell s n or m ali s e d t o c o ntr ol ( 1 0 0 % vi a bl e)  w er e c al c ul at e d f or e a c h s a m pl e a n d pl ott e d a s s h o w n. ( B) A r e pr e s e nt ati v e
Mit o  Str e s s T e st gr a p h fr o m p ati e nt # 2 s h o wi n g t h e eff e ct of 3 0 m M  At o v a q u o n e o n  mit o c h o n dri al r e s pir ati o n. ( C) A n al y si s of  Mit o  Str e s s T e st s f or b a s al a n d  m a xi m al
r e s pir ati o n a s  w ell a s f or  A T P pr o d u cti o n a s s h o w n. T h e d at a fr o m t h e hi g h e st t e st e d c o n c e ntr ati o n i n e a c h p ati e nt s a m pl e ( 6 0 m M f or L e u P 1 a n d 9 0 m M f or L e u P 2,
3 a n d 4)  w a s a n al y s e d.* p ≤ 0. 0 5, p air e d  St u d e nt ’s t-t e st. ( D) S y n er g y Fi n d er a n al y si s of t h e c o m bi n at ori al eff e ct of  At o v a q u o n e ( 3 0 a n d 6 0 m M) a n d I d ar u bi ci n
( 0. 0 0 0 8 a n d 0. 0 0 1 6 m M) i n f o ur p ati e nt s a m pl e s a s a n n ot at e d. L e u P, L e u k a e mi a p ati e nt.M ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L LA U T H O R  C O N T RI B U TI O N S
Y S, TI, T S, K P, a n d V S d esi g n e d t h e st u d y. Y S, TI, H B, a n d K G
d e v el o p e d t h e  m et h o d ol o g y.  Y S , TI, T S, K P, a n d V S a n al ys e d
t h e d at a.  Y S,  V S,  T S, a n d  K P  wr ot e a n d e dit e d t h e  m a n us cri pt.
All a ut h o r s c o nt ri b ut e d t o t h e a rti cl e a n d a p p r o v e d t h e
s u b mitt e d v ersi o n.F U N DI N G
T his pr oj e ct  w as f u n d e d b y t h e B ul g ari a n  N ati o n al S ci e n c e
F u n d ( pr oj e ct  N o.  K P- 0 6- M 2 1/ 9 / 1 9. 1 2. 1 8), a n d s u p p ort e d
b y t h e  N ati o n al  U ni v e r sit y  C o m pl e x f o r  Bi o m e di c al a n d
A p pli e d  R e s e a r c h  wit h p a rti ci p ati o n i n  B B M R I - E R I C,
N U C B PI- B B M RI. B G, ( c o ntr a cts  N o.  D 0 1- 2 8 5/ 1 7. 1 2. 2 0 1 9 a n dFr o nti er s i n  O n c ol o g y |  w w w.fr o nti er si n. or g 9D O 1- 3 9 5/ 1 8. 1 2. 2 0 2 0)  wit hi n t h e  N ati o n al  R o a d  M a p F or
R es e ar c h I nfr astr u ct ur e.A C K N O W L E D G M E N T S
W e  w o ul d li k e t o t h a n k St  G e or g e  U ni v ersit y  H os pit al ( Pl o v di v)
f or pr o vi di n g p ati e nt s a m pl es a n d cli ni c al d at a a n d  N o v o g e n e
U K f or  R N A-s e q u e n ci n g a n d i niti al d at a a n al ysis.S U P P L E M E N T A R Y  M A T E RI A L
T h e S u p pl e m e nt ar y  M at eri al f or t his arti cl e c a n b e f o u n d o nli n e
at: htt p s:// w w w.f r o nti e r si n . o r g/ a rti cl e s/ 1 0. 3 3 8 9/f o n c. 2 0 2 1.
6 3 2 1 8 1/f ull #s u p pl e m e nt ar y- m at eri alR E F E R E N C E S
1.  W ar b ur g  O,  Wi n d F,  N e g el ei n E.  T h e  M et a b olis m of  T u m ors i n t h e B o d y.
J  G e n P h ysi ol ( 1 9 2 7) 8: 5 1 9– 3 0. d oi: 1 0. 1 0 8 5/j g p. 8. 6. 5 1 9
2.  D e B er ar di nis  RJ,  C h a n d el  N S. F u n d a m e nt als of c a n c er  m et a b olis m. Sci  A d v
( 2 0 1 6) 2: e 1 6 0 0 2 0 0. d oi: 1 0. 1 1 2 6/s ci a d v. 1 6 0 0 2 0 0
3. L u e n g o  A,  G ui  D Y,  V a n d er  H ei d e n  M G.  T ar g eti n g  M et a b olis m f or  C a n c er
T h er a p y. Cell  C he m Bi ol ( 2 0 1 7) 2 4: 1 1 6 1– 8 0. d oi: 1 0. 1 0 1 6/j.c he m bi ol. 2 0 1 7. 0 8. 0 2 8
4. S bir k o v  Y, B ur n us u z o v  H, S ar a fi a n  V.  M et a b oli c r e pr o gr a m mi n g i n c hil d h o o d
a c ut e l y m p h o bl asti c l e u k e mi a. P e di atr  Bl o o d  C a nc er ( 2 0 2 0) 6 7: e 2 8 2 5 5.
d oi: 1 0. 1 0 0 2/ p b c. 2 8 2 5 5
5.  G u  Z,  C h ur c h m a n  M L,  R o b erts  K G,  M o or e I,  Z h o u  X,  N a kit a n d w e J, et al.
P A X 5- dri v e n s u bt y p es of B- pr o g e nit or a c ut e l y m p h o bl asti c l e u k e mi a. N at
G e n et ( 2 0 1 9) 5 1: 2 9 6– 3 0 7. d oi: 1 0. 1 0 3 8/s 4 1 5 8 8- 0 1 8- 0 3 1 5- 5
6. B o a g J M, B e esl e y  A H, Firt h  MJ, Fr eit as J R, F or d J,  H off m a n n  K, et al.  Alt er e d
gl u c os e  m et a b olis m i n c hil d h o o d pr e- B a c ut e l y m p h o bl asti c l e u k a e mi a.
L e u k e mi a ( 2 0 0 6) 2 0: 1 7 3 1– 7. d oi: 1 0. 1 0 3 8/sj.l e u. 2 4 0 4 3 6 5
7.  K o dr o n  A,  G h a ni m  M,  Kr a w c z y k  K K, St el m as z c z y k – E m m el  A,  T o ns k a  K,
D e m k o w  U, et al.  Mit o c h o n dri al  D N A i n p e di atri c l e u k e mi a p ati e nts. Act a
Bi oc hi m P ol ( 2 0 1 7) 6 4: 1 8 3– 7. d oi: 1 0. 1 8 3 8 8/ a b p. 2 0 1 6 _ 1 4 4 4
8. J e n ki ns o n S,  K o o  K,  M a ns o ur  M R,  G o ul d e n  N,  V or a  A,  Mit c h ell  C, et al.
I m p a ct of  N O T C H 1/ F B X W 7  m ut ati o ns o n o ut c o m e i n p e di atri c  T- c ell a c ut e
l y m p h o bl asti c l e u k e mi a p ati e nts tr e at e d o n t h e  M R C  U K A L L 2 0 0 3 tri al.
L e u k e mi a ( 2 0 1 3) 2 7: 4 1– 7. d oi: 1 0. 1 0 3 8/l e u. 2 0 1 2. 1 7 6
9.  H err a n z  D,  A m b esi – I m pi o m b at o  A, S u d d ert h J, S a n c h e z– M arti n  M, B el v er L,
T os ell o  V, et al.  M et a b oli c r e pr o gr a m mi n g i n d u c es r esist a n c e t o a nti-
N O T C H 1 t h er a pi es i n  T c ell a c ut e l y m p h o bl asti c l e u k e mi a. N at  M e d
( 2 0 1 5) 2 1: 1 1 8 2– 9. d oi: 1 0. 1 0 3 8/ n m. 3 9 5 5
1 0.  D y c z y ns ki  M,  V est erl u n d  M, Bj or kl u n d  A C,  Z a c h ari a dis  V, J a nss e n J,  G all art –
A y al a  H, et al.  M et a b oli c r e pr o gr a m mi n g of a c ut e l y m p h o bl asti c l e u k e mi a
c ells i n r es p o ns e t o gl u c o c orti c oi d tr e at m e nt. C ell  D e at h  Dis ( 2 0 1 8) 9: 8 4 6.
d oi: 1 0. 1 0 3 8/s 4 1 4 1 9- 0 1 8- 0 6 2 5- 7
1 1.  A o ki S,  M orit a  M,  Hir a o  T,  Y a m a g u c hi  M, S hir at ori  R,  Ki k u y a  M, et al. S hift i n
e n er g y  m et a b olis m c a us e d b y gl u c o c orti c oi ds e n h a n c es t h e eff e ct of c yt ot o xi c
a nti- c a n c er dr u gs a g ai nst a c ut e l y m p h o bl asti c l e u k e mi a c ells. O nc ot ar g et
( 2 0 1 7) 8: 9 4 2 7 1– 8 5. d oi: 1 0. 1 8 6 3 2/ o n c ot ar g et. 2 1 6 8 9
1 2.  Y a d a v  N,  K u m ar S,  M arl o w e  T,  C h a u d h ar y  A K,  K u m ar  R,  W a n g J, et al.
O xi d ati v e p h os p h or yl ati o n- d e p e n d e nt r e g ul ati o n of c a n c er c ell a p o pt osis i n
r es p o ns e t o a nti c a n c er a g e nts. C ell  D e at h  Dis ( 2 0 1 5) 6: e 1 9 6 9. d oi: 1 0. 1 0 3 8/
c d dis. 2 0 1 5. 3 0 5
1 3. P a n os y a n E H,  Gri g or y a n  R S,  A vr a mis I A, S ei b el  N L,  G a y n o n P S, Si e g el S E,
et al.  D e a mi n ati o n of gl ut a mi n e is a pr er e q uisit e f or o pti m al as p ar a gi n e
d e a mi n ati o n b y as p ar a gi n as es i n vi v o ( C C G- 1 9 6 1). A ntic a nc er  R es ( 2 0 0 4)
2 4: 1 1 2 1 – 5.
1 4.  H er m a n o v a I,  Arr u a b arr e n a – Arist or e n a  A,  V alis  K,  N us k o v a  H,  Al b eri c h –
J or d a  M, Fis er  K, et al. P h ar m a c ol o gi c al i n hi biti o n of f att y- a ci d o xi d ati o ns y n er gisti c all y e n h a n c es t h e eff e ct of l- as p ar a gi n as e i n c hil d h o o d  A L L c ells.
L e u k e mi a ( 2 0 1 6) 3 0: 2 0 9– 1 8. d oi: 1 0. 1 0 3 8/l e u. 2 0 1 5. 2 1 3
1 5.  U m er e z  M,  G uti err e z- C a mi n o  A,  M u n o z- M al d o n a d o  C,  M arti n- G u err er o I,
G ar ci a- Or a d A.  M T H F R p ol y m or p his ms i n c hil d h o o d a c ut e l y m p h o bl asti c
l e u k e mi a: i nfl u e n c e o n  m et h otr e x at e t h er a p y. P h ar m g e n o mics P ers  M e d
( 2 0 1 7) 1 0: 6 9– 7 8. d oi: 1 0. 2 1 4 7/ P G P M. S 1 0 7 0 4 7
1 6.  K at o  M,  M a n a b e  A.  Tr e at m e nt a n d bi ol o g y of p e di atri c a c ut e l y m p h o bl asti c
l e u k e mi a. P e di atr I nt ( 2 0 1 8) 6 0: 4– 1 2. d oi: 1 0. 1 1 1 1/ p e d. 1 3 4 5 7
1 7. B h oj w a ni  D, P ui  C H.  R el a ps e d c hil d h o o d a c ut e l y m p h o bl asti c l e u k a e mi a.
L a nc et  O nc ol ( 2 0 1 3) 1 4: e 2 0 5– 2 1 7. d oi: 1 0. 1 0 1 6/ S 1 4 7 0- 2 0 4 5( 1 2) 7 0 5 8 0- 6
1 8.  As h b ur n  T T,  T h or  K B.  Dr u g r e p ositi o ni n g: i d e ntif yi n g a n d d e v el o pi n g n e w
us es f or e xisti n g dr u gs. N at  R e v  Dr u g  Disc o v ( 2 0 0 4) 3: 6 7 3– 8 3. d oi: 1 0. 1 0 3 8/
nr d 1 4 6 8
1 9. P us h p a k o m S, I ori o F, E y ers P A, Es c ott  KJ,  H o p p er S,  W ells  A, et al.  Dr u g
r e p ur p osi n g: pr o gr ess, c h all e n g es a n d r e c o m m e n d ati o ns. N at  R e v  Dr u g  Disc o v
( 2 0 1 9) 1 8: 4 1– 5 8. d oi: 1 0. 1 0 3 8/ nr d. 2 0 1 8. 1 6 8
2 0.  N o w a k- Sli wi ns k a P, S c a p o z z a L,  R ui z i  Alt a b a  A.  Dr u g r e p ur p osi n g i n
o n c ol o g y:  C o m p o u n d s, p at h w a y s, p h e n ot y p e s a n d c o m p ut ati o n al
a p pr o a c h es f or c ol or e ct al c a n c er. Bi oc hi m Bi o p h ys  Act a  R e v  C a nc er ( 2 0 1 9)
1 8 7 1: 4 3 4 – 5 4. d oi: 1 0. 1 0 1 6/j. b b c a n. 2 0 1 9. 0 4. 0 0 5
2 1.  R u dr a p al  M,  K h air n ar SJ, J a d h a v  A G.  Dr u g  R e p ur p osi n g ( D R):  A n E m er gi n g
A p pr o a c h i n  Dr u g  Dis c o v e r y. I nt e c h O p e n ( 2 0 2 0) 1– 2 0. d oi: 1 0. 5 7 7 2/
i nt e c h o p e n. 9 3 1 9 3
2 2.  D e g os L,  W a n g  Z Y.  All tr a ns r eti n oi c a ci d i n a c ut e pr o m y el o c yti c l e u k e mi a.
O nc o g e n e ( 2 0 0 1) 2 0: 7 1 4 0– 5. d oi: 1 0. 1 0 3 8/sj. o n c. 1 2 0 4 7 6 3
2 3. S c h e n k  T,  C h e n  W C,  G oll n er S,  H o w ell L, Ji n L,  H e b estr eit  K, et al. I n hi biti o n
of t h e L S D 1 ( K D M 1 A) d e m et h yl as e r e a cti v at es t h e all-tr a ns-r eti n oi c a ci d
diff e r e nti ati o n p at h w a y i n a c ut e  m y el oi d l e u k e mi a. N at  M e d ( 2 0 1 2)
1 8: 6 0 5 – 1 1. d oi: 1 0. 1 0 3 8/ n m. 2 6 6 1
2 4.  H ail e L G, Fl a h ert y J F.  At o v a q u o n e: a r e vi e w. A n n P h ar m ac ot h er ( 1 9 9 3)
2 7: 1 4 8 8 – 9 4. d oi: 1 0. 1 1 7 7/ 1 0 6 0 0 2 8 0 9 3 0 2 7 0 1 2 1 5
2 5.  Ni x o n  G L,  M oss  D M, S h o n e  A E, L all o o  D G, Fis h er  N,  O' N eill P M, et al.
A nti m al ari al p h ar m a c ol o g y a n d t h er a p e uti cs of at o v a q u o n e. J  A nti micr o b
C h e m ot h er ( 2 0 1 3) 6 8: 9 7 7– 8 5. d oi: 1 0. 1 0 9 3/j a c/ d ks 5 0 4
2 6. Fi orill o  M, L a m b  R,  T a n o wit z  H B,  M utti L,  Krsti c – D e m o n a c os  M,  C a p p ell o
A R, et al.  R e p ur p osi n g at o v a q u o n e: t ar g eti n g  mit o c h o n dri al c o m pl e x III a n d
O X P H O S t o er a di c at e c a n c er st e m c ells. O nc ot ar g et ( 2 0 1 6) 7: 3 4 0 8 4– 9 9.
d oi: 1 0. 1 8 6 3 2/ o n c ot ar g et. 9 1 2 2
2 7.  As ht o n  T M, F o k as E,  K u n z – S c h u g h art L A, F ol k es L K,  A n b al a g a n S,  H u et h er
M, et al.  T h e a nti- m al ari al at o v a q u o n e i n cr e as es r a di os e nsiti vit y b y all e vi ati n g
t u m o ur h y p o xi a. N at  C o m m u n ( 2 0 1 6) 7: 1 2 3 0 8. d oi: 1 0. 1 0 3 8/ n c o m ms 1 2 3 0 8
2 8.  K e F,  Y u J,  C h e n  W, Si  X, Li  X,  Y a n g F, et al.  T h e a nti- m al ari al at o v a q u o n e
s el e cti v el y i n cr e as es c h e m os e nsiti vit y i n r eti n o bl ast o m a vi a mit o c h o n dri al
d ysf u n cti o n- d e p e n d e nt o xi d ati v e d a m a g e a n d  A kt/ A M P K/ m T O R i n hi biti o n.
Bi o c h e m  Bi o p h ys  R es  C o m m u n ( 2 0 1 8) 5 0 4: 3 7 4– 9. d oi: 1 0. 1 0 1 6/j. b br c.
2 0 1 8. 0 6. 0 4 9M ar c h 2 0 2 1 | V ol u m e 1 1 |  Arti cl e 6 3 2 1 8 1
S bir k o v et al. Eff e ct of  At o v a q u o n e i n c A L L2 9.  D a s S,  Di el s c h n ei d e r  R,  C h a n a s- L a R u e  A, J o h n st o n J B,  Gi b s o n S B.
A nti m al a ri al d r u g s t ri g g e r l y s o s o m e- m e di at e d c ell d e at h i n c h r o ni c
l y m p h o c yti c l e u k e mi a ( C L L) c ells. L e u k  R es ( 2 0 1 8) 7 0: 7 9– 8 6. d oi: 1 0. 1 0 1 6/
j.l e u kr es. 2 0 1 8. 0 6. 0 0 5
3 0.  Xi a n g  M,  Ki m  H,  H o  V T,  W al k er S R, B ar – N at a n  M,  A n a ht ar  M, et al.  G e n e
e x p r e s si o n- b a s e d di s c o v e r y of at o v a q u o n e as a S T A T 3 i n hi bit o r a n d
a nti c a n c er a g e nt. Bl o o d ( 2 0 1 6) 1 2 8: 1 8 4 5– 5 3. d oi: 1 0. 1 1 8 2/ bl o o d- 2 0 1 5- 0 7-
6 6 0 5 0 6
3 1. I a n e vs ki  A,  Giri  A K,  Aitt o k alli o  T. S y n er g y Fi n d er 2. 0: vis u al a n al yti cs of
m ulti- dr u g c o m bi n ati o n s y n er gi es. N ucl eic  Aci ds  R es ( 2 0 2 0) 4 8: W 4 8 8– 9 3.
d oi: 1 0. 1 0 9 3/ n ar/ g k a a 2 1 6
3 2.  Y a d a v B,  W e n n er b er g  K,  Aitt o k alli o  T,  T a n g J. S e ar c hi n g f or  Dr u g S y n er g y i n
C o m pl e x  D os e- R es p o ns e L a n ds c a p es  Usi n g a n I nt er a cti o n P ot e n c y  M o d el.
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